EDISON, N.J., May 12 /PRNewswire/ -- Informed Medical Communications (IMC), a leading provider of peer-to-peer medical forums for the bio-pharmaceutical industry, today announced the appointment of Scott Stoogenke, as Vice President, Marketing. In this role, Stoogenke will develop and implement marketing strategies for Peer Group, RxDialogue and IMC with the objective to maintain and grow IMC's leadership position in the industry.
Stoogenke joins IMC with over 15 years of life sciences marketing experience, including pharmaceutical brand management and service provider marketing leadership. Most recently, he worked for Covance, Inc. as Director of Corporate Marketing, managing the corporate branding initiative, conferences, e-marketing, and marketing communications. Previously, he worked for PDI, Inc. as Executive Director of Marketing, providing strategic corporate marketing and business development support. His experience also includes a breadth of marketing roles at GlaxoSmithKline and Novo Nordisk, including product management, market research, forecasting, competitive intelligence, managed care marketing, and pipeline development in multiple therapeutic areas.
In addition to his work experience, Stoogenke holds an MBA in marketing/international business from the University of Maryland Smith School of Business, an MA in education/human development from the George Washington University, and a BS in biochemistry/molecular biology from the University of Maryland.
"We are delighted to have someone with Scott's qualifications and enthusiasm join our organization in this capacity," said Steve Budd, CEO of IMC. "Scott's proven expertise in branding and marketing strategy coupled with his experience on both the client and service side of the table provides a perfect fit as we continue to grow our business."
About Informed Medical Communications
Informed Medical Communications (http://www.informedmedical.com), headquartered in Edison, NJ, is an interactive medical marketing group of companies providing services to the biopharmaceutical industry. The companies include The Peer Group and RxDialogue, industry innovators and leaders in conducting general and specialty peer-to-peer medical programs, respectively. Additionally, IMC's major businesses are enhanced by MRxHealth, the market research and consulting infrastructure that supports IMC's ongoing development and effectiveness of non-traditional marketing programs for biopharmaceutical clients, and Leading Through Dialogue, a communications training service for elite skill development in three areas: (1) leadership, (2) sales, and (3) training/facilitation. The IMC network of companies delivers integrated marketing programs for pharmaceutical marketers, with the goal of improving the dialogue among healthcare practitioners in understanding health conditions and their medical options. IMC is a private-equity backed, privately held company.
|SOURCE Informed Medical Communications|
Copyright©2008 PR Newswire.
All rights reserved